Ali Bazarbachi, MD, PhD is a Professor of Medicine (Hematology and Oncology), Professor of Anatomy, Cell Biology and Physiological Sciences, and Founding Director of the bone marrow transplantation program at the American University of Beirut-Medical Center. He received his MD and PhD degrees, residency and fellowship training at the University of Paris in France. Dr. Ali Bazarbachi’s basic and translational research focuses on targeted therapies for hematological malignancies as well as post-transplant pharmacological interventions. He has co-authored more than 360 articles in leading scientific journals, including The New England Journal of Medicine, Science, Journal of Experimental Medicine, The Lancet Oncology, Journal of Clinical Oncology, Blood, Nature Communication, and Cancer Research. He is a co-founder of the International Academy for Clinical Hematology, the Chairman of the EMBMT Leukemia Working Party, Chairman of the NCCN Lymphoma Group for Middle East and North Africa, past President of the Lebanese Society of Hematology, past President of the International Association for Comparative Research on Leukemia and Related Disorders, and Associate Editor of “Bone Marrow Transplantation” and of “Clinical Hematology International”.
He garnered multiple prestigious national and international awards, including the 2008 award of the French National Academy of Medicine, the 2022 King Hussein Lifetime Achievement Award for Cancer Research, and the Lebanese National Medal of Merit.